{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:20:34Z","timestamp":1790108434884,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270858"],"award-info":[{"award-number":["82270858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470869"],"award-info":[{"award-number":["82470869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2024A1515012925"],"award-info":[{"award-number":["2024A1515012925"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06329-1","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:22:39Z","timestamp":1742278959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNA-24-3p targeting Top1 in perirenal fat is involved in circulating inflammation and high cardiovascular disease risk in patients with primary aldosteronism"],"prefix":"10.1186","volume":"23","author":[{"given":"Xuelin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"issue":"2","key":"6329_CR1","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3390\/ijms25020900","volume":"25","author":"N Ekman","year":"2024","unstructured":"Ekman N, Grossman AB, Dworakowska D. What we know about and what is new in primary aldosteronism. Int J Mol Sci. 2024;25(2):900.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"6329_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","volume":"138","author":"JB Byrd","year":"2018","unstructured":"Byrd JB, Turcu AF, Auchus RJ. Primary aldosteronism: practical approach to diagnosis and management. Circulation. 2018;138(8):823\u201335.","journal-title":"Circulation"},{"issue":"8","key":"6329_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45(8):1243\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"6329_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69(14):1811\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6329_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41440-023-01482-w","volume":"47","author":"YL Chen","year":"2024","unstructured":"Chen YL, Chen CH, Xu TY, Xu JZ, Zhu LM, Li Y, et al. Non-invasive left ventricular pressure-strain loop study on cardiac fibrosis in primary aldosteronism: a comparative study with cardiac magnetic resonance imaging. Hypertens Res. 2024;47(2):445\u201354.","journal-title":"Hypertens Res"},{"issue":"3","key":"6329_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","volume":"60","author":"M Reincke","year":"2012","unstructured":"Reincke M, Fischer E, Gerum S, Merkle K, Schulz S, Pallauf A, et al. Observational study mortality in treated primary aldosteronism: the German Conn\u2019s registry. Hypertension. 2012;60(3):618\u201324.","journal-title":"Hypertension"},{"issue":"1","key":"6329_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1210\/en.2017-00651","volume":"159","author":"C Wu","year":"2018","unstructured":"Wu C, Zhang H, Zhang J, Xie C, Fan C, Zhang H, et al. Inflammation and fibrosis in perirenal adipose tissue of patients with aldosterone-producing adenoma. Endocrinology. 2018;159(1):227\u201337.","journal-title":"Endocrinology"},{"issue":"11","key":"6329_CR8","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCRESAHA.115.306885","volume":"118","author":"JJ Fuster","year":"2016","unstructured":"Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118(11):1786\u2013807.","journal-title":"Circ Res"},{"issue":"4","key":"6329_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4239\/wjd.v11.i4.115","volume":"11","author":"N Huang","year":"2020","unstructured":"Huang N, Mao EW, Hou NN, Liu YP, Han F, Sun XD. Novel insight into perirenal adipose tissue: a neglected adipose depot linking cardiovascular and chronic kidney disease. World J Diabetes. 2020;11(4):115\u201325.","journal-title":"World J Diabetes"},{"issue":"7","key":"6329_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/0003319718799967","volume":"70","author":"BX Liu","year":"2019","unstructured":"Liu BX, Sun W, Kong XQ. Perirenal fat: a unique fat pad and potential target for cardiovascular disease. Angiology. 2019;70(7):584\u201393.","journal-title":"Angiology"},{"issue":"6","key":"6329_CR11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1055\/a-1116-2366","volume":"52","author":"Z Tombol","year":"2020","unstructured":"Tombol Z, Turai PI, Decmann A, Igaz P. MicroRNAs and adrenocortical tumors: where do we stand on primary aldosteronism? Horm Metab Res. 2020;52(6):394\u2013403.","journal-title":"Horm Metab Res"},{"issue":"3","key":"6329_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA. Trials and tribulations of MicroRNA therapeutics. Int J Mol Sci. 2024;25(3):1469.","journal-title":"Int J Mol Sci"},{"issue":"1009","key":"6329_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1259\/bjr\/38447238","volume":"85","author":"A Shuster","year":"2012","unstructured":"Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1\u201310.","journal-title":"Br J Radiol"},{"issue":"3","key":"6329_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01102","volume":"62","author":"S Robertson","year":"2013","unstructured":"Robertson S, MacKenzie SM, Alvarez-Madrazo S, Diver LA, Lin J, Stewart PM, et al. MicroRNA-24 is a novel regulator of aldosterone and cortisol production in the human adrenal cortex. Hypertension. 2013;62(3):572\u20138.","journal-title":"Hypertension"},{"issue":"6","key":"6329_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.111.039008","volume":"124","author":"J Fiedler","year":"2011","unstructured":"Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D, et al. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation. 2011;124(6):720\u201330.","journal-title":"Circulation"},{"issue":"22","key":"6329_CR16","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1182\/blood-2015-01-620278","volume":"125","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Cheng J, Wang D, Hu X, Xie Y, Stitham J, et al. Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor. Blood. 2015;125(22):3377\u201387.","journal-title":"Blood"},{"issue":"11","key":"6329_CR17","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/jac\/dku264","volume":"69","author":"N Squillace","year":"2014","unstructured":"Squillace N, Bresciani E, Torsello A, Bandera A, Sabbatini F, Giovannetti C, et al. Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients. J Antimicrob Chemother. 2014;69(11):3067\u201375.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"6329_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032542","volume":"7","author":"S Wan","year":"2012","unstructured":"Wan S, Pestka S, Jubin RG, Lyu YL, Tsai YC, Liu LF. Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells. PLoS ONE. 2012;7(3): e32542.","journal-title":"PLoS ONE"},{"issue":"9","key":"6329_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1248\/yakushi.22-00094","volume":"142","author":"Y Kitai","year":"2022","unstructured":"Kitai Y. Elucidation of the mechanism of topotecan-induced antitumor immune activation. Yakugaku Zasshi. 2022;142(9):911\u20136.","journal-title":"Yakugaku Zasshi"},{"issue":"6289","key":"6329_CR20","doi-asserted-by":"publisher","first-page":"d7993","DOI":"10.1126\/science.aad7993","volume":"352","author":"A Rialdi","year":"2016","unstructured":"Rialdi A, Campisi L, Zhao N, Lagda AC, Pietzsch C, Ho J, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science. 2016;352(6289):d7993.","journal-title":"Science"},{"issue":"10","key":"6329_CR21","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1016\/j.cell.2021.03.051","volume":"184","author":"J Ho","year":"2021","unstructured":"Ho J, Mok BW, Campisi L, Jordan T, Yildiz S, Parameswaran S, et al. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell. 2021;184(10):2618\u201332.","journal-title":"Cell"},{"key":"6329_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104368","volume":"148","author":"N Yang","year":"2019","unstructured":"Yang N, Yue R, Ma J, Li W, Zhao Z, Li H, et al. Nitidine chloride exerts anti-inflammatory action by targeting Topoisomerase I and enhancing IL-10 production. Pharmacol Res. 2019;148: 104368.","journal-title":"Pharmacol Res"},{"issue":"5","key":"6329_CR23","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(5):1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6329_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6(1):41\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"6329_CR25","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.2337\/db20-1031","volume":"70","author":"X Chen","year":"2021","unstructured":"Chen X, Mao Y, Hu J, Han S, Gong L, Luo T, et al. Perirenal fat thickness is significantly associated with the risk for development of chronic kidney disease in patients with diabetes. Diabetes. 2021;70(10):2322\u201332.","journal-title":"Diabetes"},{"issue":"4","key":"6329_CR26","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.4238\/2013.November.7.1","volume":"12","author":"M Kang","year":"2013","unstructured":"Kang M, Yan LM, Li YM, Zhang WY, Wang H, Tang AZ, et al. Inhibitory effect of microRNA-24 on fatty acid-binding protein expression on 3T3-L1 adipocyte differentiation. Genet Mol Res. 2013;12(4):5267\u201377.","journal-title":"Genet Mol Res"},{"issue":"1","key":"6329_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bbrc.2016.04.073","volume":"474","author":"M Jin","year":"2016","unstructured":"Jin M, Wu Y, Wang J, Chen J, Huang Y, Rao J, et al. MicroRNA-24 promotes 3T3-L1 adipocyte differentiation by directly targeting the MAPK7 signaling. Biochem Biophys Res Commun. 2016;474(1):76\u201382.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"6329_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tem.2008.01.006","volume":"19","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab. 2008;19(3):88\u201390.","journal-title":"Trends Endocrinol Metab"},{"key":"6329_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mce.2015.04.007","volume":"411","author":"E Martinez-Martinez","year":"2015","unstructured":"Martinez-Martinez E, Cachofeiro V, Rousseau E, Alvarez V, Calvier L, Fernandez-Celis A, et al. Interleukin-33\/ST2 system attenuates aldosterone-induced adipogenesis and inflammation. Mol Cell Endocrinol. 2015;411:20\u20137.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"6329_CR30","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","volume":"132","author":"CM Rondinone","year":"1993","unstructured":"Rondinone CM, Rodbard D, Baker ME. Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology. 1993;132(6):2421\u20136.","journal-title":"Endocrinology"},{"issue":"17","key":"6329_CR31","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","volume":"117","author":"C Guo","year":"2008","unstructured":"Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation. 2008;117(17):2253\u201361.","journal-title":"Circulation"},{"issue":"10","key":"6329_CR32","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/aps.2013.47","volume":"34","author":"R Zhou","year":"2013","unstructured":"Zhou R, Lin ZH, Jiang CS, Gong JX, Chen LL, Guo YW, et al. Marine natural product des-O-methyllasiodiplodin effectively lowers the blood glucose level in db\/db mice via ameliorating inflammation. Acta Pharmacol Sin. 2013;34(10):1325\u201336.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"6329_CR33","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1210\/en.2008-1018","volume":"150","author":"T Wada","year":"2009","unstructured":"Wada T, Ohshima S, Fujisawa E, Koya D, Tsuneki H, Sasaoka T. Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes. Endocrinology. 2009;150(4):1662\u20139.","journal-title":"Endocrinology"},{"issue":"1","key":"6329_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111948","volume":"42","author":"Y Tang","year":"2023","unstructured":"Tang Y, Yang LJ, Liu H, Song YJ, Yang QQ, Liu Y, et al. Exosomal miR-27b-3p secreted by visceral adipocytes contributes to endothelial inflammation and atherogenesis. Cell Rep. 2023;42(1): 111948.","journal-title":"Cell Rep"},{"issue":"5","key":"6329_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/ten.tea.2008.0101","volume":"15","author":"N Lai","year":"2009","unstructured":"Lai N, Jayaraman A, Lee K. Enhanced proliferation of human umbilical vein endothelial cells and differentiation of 3T3-L1 adipocytes in coculture. Tissue Eng Part A. 2009;15(5):1053\u201361.","journal-title":"Tissue Eng Part A"},{"issue":"3","key":"6329_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/10520295.2021.1923801","volume":"97","author":"S Pourdashti","year":"2022","unstructured":"Pourdashti S, Faridi N, Yaghooti H, Jalali MT, Soroush A, Bathaie SZ. Possible role of WNT10B in increased proliferation and tubule formation of human umbilical vein endothelial cell cultures treated with hypoxic conditioned medium from human adipocytes. Biotech Histochem. 2022;97(3):168\u201379.","journal-title":"Biotech Histochem"},{"issue":"7","key":"6329_CR37","first-page":"1722","volume":"48","author":"YH Hsiang","year":"1988","unstructured":"Hsiang YH, Liu LF. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 1988;48(7):1722\u20136.","journal-title":"Cancer Res"},{"issue":"27","key":"6329_CR38","doi-asserted-by":"publisher","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","volume":"260","author":"YH Hsiang","year":"1985","unstructured":"Hsiang YH, Hertzberg R, Hecht S, Liu LF. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 1985;260(27):14873\u20138.","journal-title":"J Biol Chem"},{"key":"6329_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0065-230X(01)80016-6","volume":"80","author":"P Pourquier","year":"2001","unstructured":"Pourquier P, Pommier Y. Topoisomerase I-mediated DNA damage. Adv Cancer Res. 2001;80:189\u2013216.","journal-title":"Adv Cancer Res"},{"issue":"7","key":"6329_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ctrv.2006.07.001","volume":"32","author":"C Fuchs","year":"2006","unstructured":"Fuchs C, Mitchell EP, Hoff PM. Irinotecan in the treatment of colorectal cancer. Cancer Treat Rev. 2006;32(7):491\u2013503.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"6329_CR41","first-page":"1087","volume":"3","author":"J Garst","year":"2007","unstructured":"Garst J. Topotecan: an evolving option in the treatment of relapsed small cell lung cancer. Ther Clin Risk Manag. 2007;3(6):1087\u201395.","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"6329_CR42","first-page":"1455","volume":"4","author":"M Crul","year":"2003","unstructured":"Crul M. CKD-602. Chong Kun Dang. Curr Opin Investig Drugs. 2003;4(12):1455\u20139.","journal-title":"Curr Opin Investig Drugs"},{"issue":"4","key":"6329_CR43","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.cell.2018.07.040","volume":"174","author":"MP Dragomir","year":"2018","unstructured":"Dragomir MP, Knutsen E, Calin GA. SnapShot: unconventional miRNA functions. Cell. 2018;174(4):1038.","journal-title":"Cell"},{"issue":"2","key":"6329_CR44","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/med.21997","volume":"44","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Li Y, Li M, Wang R, Jiang Y, Zhao M, et al. COVID-19 cooling: nanostrategies targeting cytokine storm for controlling severe and critical symptoms. Med Res Rev. 2024;44(2):738\u2013811.","journal-title":"Med Res Rev"},{"issue":"9","key":"6329_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29076","volume":"95","author":"S Hao","year":"2023","unstructured":"Hao S, Ning K, Kuz CA, Xiong M, Zou W, Park SY, et al. SARS-CoV-2 infection of polarized human airway epithelium induces necroptosis that causes airway epithelial barrier dysfunction. J Med Virol. 2023;95(9): e29076.","journal-title":"J Med Virol"},{"issue":"7","key":"6329_CR46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/iju.14248","volume":"27","author":"A Ochi","year":"2020","unstructured":"Ochi A, Muro S, Adachi T, Akita K. Zoning inside the renal fascia: The anatomical relationship between the urinary system and perirenal fat. Int J Urol. 2020;27(7):625\u201333.","journal-title":"Int J Urol"},{"issue":"7","key":"6329_CR47","first-page":"2343","volume":"82","author":"G Path","year":"1997","unstructured":"Path G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. J Clin Endocrinol Metab. 1997;82(7):2343\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"6329_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1749-6632.2002.tb04230.x","volume":"966","author":"HS Willenberg","year":"2002","unstructured":"Willenberg HS, Path G, Vogeli TA, Scherbaum WA, Bornstein SR. Role of interleukin-6 in stress response in normal and tumorous adrenal cells and during chronic inflammation. Ann N Y Acad Sci. 2002;966:304\u201314.","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06329-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T06:58:37Z","timestamp":1742281117000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06329-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6329"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06329-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the ethics committee of Southern Medical University, and written informed consent was obtained from all the patients (No: NFEC-2021-049).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}